Our faculty author, co-author and contribute to more than 1500 peer-reviewed scientific publications each year. Find their recent publications below, and filter by division.
Search the faculty directory to find an individual's list of publications.
Publications
Blumer, Vanessa, Manuel Rivera, Ramón Corbalán, Richard C. Becker, Scott D. Berkowitz, Günter Breithardt, Werner Hacke, et al. “Rivaroxaban versus warfarin in patients with atrial fibrillation enrolled in Latin America: Insights from ROCKET AF.” Am Heart J 236 (June 2021): 4–12. https://doi.org/10.1016/j.ahj.2021.02.004.
PMID
33571477
Giarraputo, James, Stephanie Giamberardino, Stephanie Arvai, Sarah Maichle, Christopher Eckstein, L Kristin Newby, and Simon Gregory. “Profiling serum neurofilament light chain and glial fibrillary acidic protein in primary progressive multiple sclerosis.” J Neuroimmunol 354 (May 15, 2021): 577541. https://doi.org/10.1016/j.jneuroim.2021.577541.
PMID
33725477
Alenezi, Fawaz, and Sudarshan Rajagopal. “The right atrium, more than a storehouse.” Int J Cardiol 331 (May 15, 2021): 329–30. https://doi.org/10.1016/j.ijcard.2021.01.069.
PMID
33548383
Carnicelli, Anthony P., Sana M. Al-Khatib, Denis Xavier, Frederik Dalgaard, Peter D. Merrill, Daniel M. Wojdyla, Basil S. Lewis, et al. “Premature permanent discontinuation of apixaban or warfarin in patients with atrial fibrillation.” Heart 107, no. 9 (May 2021): 713–20. https://doi.org/10.1136/heartjnl-2020-317229.
PMID
32938772
Steinberg, Benjamin A., Zhen Li, Emily C. O’Brien, Jessica Pritchard, Derek S. Chew, T Jared Bunch, Daniel B. Mark, Yelena Nabutovsky, Melissa A. Greiner, and Jonathan P. Piccini. “Atrial fibrillation burden and heart failure: Data from 39,710 individuals with cardiac implanted electronic devices.” Heart Rhythm 18, no. 5 (May 2021): 709–16. https://doi.org/10.1016/j.hrthm.2021.01.021.
PMID
33508517
Barbas, Andrew S., Jacob N. Schroder, Deeplaxmi P. Borle, Arturo Suarez, Nader Abraham, Michael W. Manning, Timothy E. Miller, et al. “Planned Initiation of Venoarterial Extracorporeal Membrane Oxygenation Prior to Liver Transplantation in a Patient With Severe Portopulmonary Hypertension.” Liver Transpl 27, no. 5 (May 2021): 760–62. https://doi.org/10.1002/lt.25871.
PMID
32799425
Clegg, Lindsay E., Yankang Jing, Robert C. Penland, David W. Boulton, Adrian F. Hernandez, Rury R. Holman, and Jiten Vora. “Cardiovascular and renal safety of metformin in patients with diabetes and moderate or severe chronic kidney disease: Observations from the EXSCEL and SAVOR-TIMI 53 cardiovascular outcomes trials.” Diabetes Obes Metab 23, no. 5 (May 2021): 1101–10. https://doi.org/10.1111/dom.14313.
PMID
33394543
Albert, Nancy M., Rachel J. Tyson, C Larry Hill, Adam D. DeVore, John A. Spertus, Carol Duffy, Javed Butler, et al. “Variation in use and dosing escalation of renin angiotensin system, mineralocorticoid receptor antagonist, angiotensin receptor neprilysin inhibitor and beta-blocker therapies in heart failure and reduced ejection fraction: Association of comorbidities.” Am Heart J 235 (May 2021): 82–96. https://doi.org/10.1016/j.ahj.2021.01.017.
PMID
33497697
Shahid, Izza, Muhammad Abdullah Nizam, Muhammad Shariq Usman, Muhammad Shahzeb Khan, Marat Fudim, and Erin D. Michos. “Meta-Analysis Comparing the Safety and Efficacy of Dual Versus Single Antiplatelet Therapy After Transcatheter Aortic Valve Implantation.” Am J Cardiovasc Drugs 21, no. 3 (May 2021): 373–76. https://doi.org/10.1007/s40256-021-00466-w.
PMID
33634434
Greene, Stephen J., Eric J. Velazquez, Kevin J. Anstrom, Eric L. Eisenstein, Shelly Sapp, Shelby Morgan, Tina Harding, et al. “Pragmatic Design of Randomized Clinical Trials for Heart Failure: Rationale and Design of the TRANSFORM-HF Trial.” Jacc Heart Fail 9, no. 5 (May 2021): 325–35. https://doi.org/10.1016/j.jchf.2021.01.013.
PMID
33714745